 BOSTON, MA ACCESSWIRE June 2, 2022 Pieris Pharmaceuticals, Inc. NASDAQ:PIRS, a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that management is scheduled to present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 8:00 AM EDT. A webcast of the companys presentation will be available at this link. 